Abstinence at end of treatment ‐ heterozygous or homozygous minor · people who smoke
Active NRT probably leads to lower abstinence at end of treatment ‐ heterozygous or homozygous minor compared with placebo ‐ rs16969968 ‐ non‐Hispanic black or African American (moderate certainty).
1 finding from 1 review
End of treatment ‐ homozygous minor · people who smoke
Active NRT showed no clear difference in end of treatment ‐ homozygous minor compared with placebo ‐ rs 588765 ‐ non‐Hispanic white (low certainty).
1 finding from 1 review
6‐Month abstinence ‐ heterozygous or homozygous minor · people who smoke
Active NRT showed no clear difference in 6‐Month abstinence ‐ heterozygous or homozygous minor compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (moderate certainty).
1 finding from 1 review
End of treatment ‐ heterozygous or homozygous minor · people who smoke
Active NRT showed no clear difference in end of treatment ‐ heterozygous or homozygous minor compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (moderate certainty).
1 finding from 1 review
6‐Month abstinence ‐ homozygous minor · people who smoke
It is very uncertain whether active NRT changes 6‐Month abstinence ‐ homozygous minor compared with placebo ‐ DRD4 (exon 3 48 bp) ‐ non‐Hispanic white (very low certainty).
1 finding from 1 review
End of treatment ‐ homozygous minor · people who smoke
Active NRT showed no clear difference in end of treatment ‐ homozygous minor compared with placebo ‐ DRD4 (exon 3 48 bp) ‐ non‐Hispanic white (low certainty).
1 finding from 1 review
Abstinence at end of treatment ‐ homozygous minor · people who smoke
Active NRT may leads to higher abstinence at end of treatment ‐ homozygous minor compared with placebo ‐ rs1051730 ‐ non‐Hispanic white (low certainty).
1 finding from 1 review
End of treatment ‐ homozygous minor · people who smoke
Active NRT showed no clear difference in end of treatment ‐ homozygous minor compared with placebo ‐ rs16969968 ‐ non‐Hispanic white (low certainty).
1 finding from 1 review
Minor adverse events
Desmopressin showed no clear difference in minor adverse events compared with placebo (low certainty).
2 findings from 1 review
Minor adverse events ‐ not reported
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse events
It is very uncertain whether desmopressin changes minor adverse events compared with alpha‐blocker (very low certainty).
1 finding from 1 review
Minor adverse events
It is very uncertain whether desmopressin plus alpha‐blocker changes minor adverse events compared with alpha‐blocker (very low certainty).
1 finding from 1 review
Minor adverse events
Desmopressin plus alpha‐blocker may leads to lower minor adverse events compared with alpha‐blocker plus anticholinergic (low certainty).
1 finding from 1 review
Minor adverse events · sexually active adults
It is very uncertain whether macrolides changes minor adverse events compared with any other antibiotic (very low certainty).
1 finding from 1 review
Minor adverse events · sexually active adults
It is very uncertain whether macrolide (erythromycin) changes minor adverse events compared with any other macrolide (very low certainty).
1 finding from 1 review
Minor morbidity: total · women > 6 weeks postpartum requesting tubal sterilisation
Summary of findings: modified Pomeroy partial salpingectomy may leads to higher minor morbidity: total compared with electrocoagulation (low certainty).
1 finding from 1 review
Minor morbidity: procedure‐related injuries with no additional operation · women > 6 weeks postpartum requesting tubal sterilisation
Summary of findings: modified Pomeroy partial salpingectomy showed no clear difference in minor morbidity: procedure‐related injuries with no additional… compared with electrocoagulation (moderate certainty).
1 finding from 1 review
Minor morbidity: total · women > 6 weeks postpartum requesting tubal sterilisation
Summary of findings: tubal ring showed no clear difference in minor morbidity: total compared with electrocoagulation (moderate certainty).
1 finding from 1 review
Minor morbidity: total · women > 6 weeks postpartum requesting tubal sterilisation
Summary of findings: ring leads to higher minor morbidity: total compared with clip (high certainty).
1 finding from 1 review
Minor morbidity: total · women requesting postpartum or interval sterilisation
Summary of findings: partial salpingectomy showed no clear difference in minor morbidity: total compared with clip (low certainty).
1 finding from 1 review